Our study suggests that combining REG4 with CA125 and HE4 could provide added value for preoperative diagnostics of ovarian masses of potential neoplastic origin, and enable distinction of mucinous ovarian cancer from other ovarian cancer subtypes with non-invasive methods. This evidence concerns the gene MUC16 and mucinous ovarian cancer.